Skip to main content
Premium Trial:

Request an Annual Quote

Fighting It Out Over RNAi

The Max Planck Society for the Advancement of Science and Alnylam Pharmaceuticals are suing the Massachusetts Institute of Technology, the Whitehead Institute for Biomedical Research, and the University of Massachusetts, "alleging that they had 'usurped' inventions that 'rightfully belong to Max Planck,'" reports Science Insider. Our sister publication RNAi News adds that Alnylam says it has patent- and patent application-licensing agreements worth about $640 million though the field is moving away from using conventional siRNAs that is "raising questions about the ultimate value of the IP."

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.